Immunovant, Inc.
IMVTNasdaqCIK 1764013HealthcareFiscal year ends Mar 31
Reports and events: 145 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-09-2817:23 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-245815 |
| 2023-09-2607:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000114 |
| 2023-08-2316:48 ET | 8-K | 5.07 Shareholder vote results | 0001764013-23-000097 |
| 2023-08-1007:19 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001764013-23-000092 |
| 2023-08-1007:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-23-000090 |
| 2023-06-2607:26 ET | DEF 14A | Proxy statementPeriod 2023-08-21 | 0001764013-23-000072 |
| 2023-05-2207:10 ET | 10-K | Annual reportPeriod 2023-03-31 | 0001764013-23-000065 |
| 2023-05-2207:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000063 |
| 2023-03-2707:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000026 |
| 2023-02-0307:17 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001764013-23-000022 |
| 2023-02-0307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-23-000020 |
| 2023-01-0908:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000003 |
| 2022-12-0807:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-22-000143 |
| 2022-11-0407:21 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001764013-22-000140 |
| 2022-11-0407:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-22-000139 |
| 2022-10-0417:28 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-257688 |
| 2022-09-2810:49 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-22-000118 |
| 2022-09-0706:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-22-000114 |
| 2022-08-1917:01 ET | 8-K | 5.07 Shareholder vote results | 0001764013-22-000108 |
| 2022-08-0507:17 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001764013-22-000085 |
| 2022-08-0507:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-22-000083 |
| 2022-06-3007:08 ET | DEF 14A | Proxy statementPeriod 2022-03-31 | 0001764013-22-000066 |
| 2022-06-0807:09 ET | 10-K | Annual reportPeriod 2022-03-31 | 0001764013-22-000059 |
| 2022-06-0807:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-22-000057 |
| 2022-03-3007:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-22-000033 |
| 2022-02-0407:22 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001764013-22-000031 |
| 2022-02-0407:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-22-000029 |
| 2022-01-0715:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-22-000007 |
| 2022-01-0507:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-22-000002 |
| 2021-12-3007:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-21-000129 |
| 2021-11-2316:27 ET | 8-K | 1.01 Entry into a material agreement | 0001764013-21-000127 |
| 2021-11-1708:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-21-000123 |
| 2021-11-0507:48 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001764013-21-000119 |
| 2021-11-0507:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-21-000117 |
| 2021-09-2708:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-21-000102 |
| 2021-09-1507:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-21-000098 |
| 2021-08-1216:37 ET | DEF 14A | Proxy statementPeriod 2021-09-09 | 0001764013-21-000083 |
| 2021-08-0907:09 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001764013-21-000079 |
| 2021-08-0906:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-21-000077 |
| 2021-08-0208:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-21-098576 |
| 2021-08-0208:09 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-21-000061 |
| 2021-07-1317:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001764013-21-000058 |
| 2021-06-0107:40 ET | 10-K | Annual reportPeriod 2021-03-31 | 0001764013-21-000052 |
| 2021-06-0107:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-21-000051 |
| 2021-03-0808:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-21-032967 |
| 2021-02-1608:24 ET | 8-K | 2.02 Results of operations | 0001764013-21-000019 |
| 2021-02-1608:24 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001764013-21-000018 |
| 2021-02-0206:52 ET | 8-K | 8.01 Other events | 0001764013-21-000012 |
| 2020-11-1208:30 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001764013-20-000063 |
| 2020-11-1208:28 ET | 8-K | 2.02 Results of operations | 0001764013-20-000062 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:26 ET. Listed shows no prices and gives no investment advice.